Objectives To assess the rate of obtaining intraoperative eSRT measurements in primary cochlear implant (CI) recipients while limiting the use of volatile anesthetics, such as sevoflurane. Methods In this prospective cohort study, thirty-one patients who underwent CI surgery with a Cochlear Americas device from January 2023 through March 2024 were included. Intraoperative eSRT testing at electrodes E1, E6, E12, E17, and E22 was performed on all patients.